TCT-401: Determining a Troponin I Threshold for Predicting 30-Day Mortality: Results from the Troponin I In the Emergency Room (TiER) Study  by unknown
TUESDAY, NOVEMBER 8, 2011, 8:00 AM - 10:00 AM
hemodynamics during elective PCI.
Methods: A total of 15 patients with stable angina were included. The coronary sinus
(CS) catheter was introduced by the right femoral vein route. Left anterior descending
artery (LAD) distal pressure was continuously measured using a sensor-equipped guide
wire. Balloon occlusion of the LAD was performed twice, lasting maximally 3 minutes
each, to document the effect of PICSO® on CS pressure (CSP) and distal LAD wedge
pressure. An occlusion was performed once with PICSO® and once without PICSO®.
Results: Catheter delivery was successful in all patients (mean duration 12.7±6.5
minutes). The study protocol could not be completed in 5 out of 15 patients due to
initial calibration problems (n=3), a pressure wire problem (n=1) and a vagal response
(n=1). In the other 10 study patients, the procedure was uncomplicated and no device-
related events occurred during 54±29 days follow up. During LAD occlusion, CS
occlusion caused a marked increase in mean CSP (4.1±7.3 mmHg vs. 22.0±12.6
mmHg; P<0.001) and CS pulse pressure (4.3±0.8 mmHg vs. 36.1±6.3 mmHg;
P<0.001). Concomitantly, mean distal LAD wedge pressure (32.4±12.2 mmHg vs.
35.5±12.6 mmHg; P<0.001) and distal LAD wedge pulse pressure (39.1±27.2 mmHg
vs. 45.9±26.0 mmHg; P<0.001) increased (figure).
Conclusion: PICSO® is safe and feasible in the cardiac catheterization laboratory
using femoral vein access. PICSO® augments CSP leading to an increase in coronary
wedge pressure.
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Background: Only a few studies presented concerning anemia because of its
association with myocardial ischemia, and demonstrated that anemia is an independent
predictor of high 30-day major adverse cardiac and cerebrovascular events (MACCEs)
and 1-year MACEs after percutaneous coronary intervention (PCI).
Methods: Anemia was defined by WHO criteria (hemoglobin below 12 g/dL for
female and below 13 g/dL for male subjects). Laboratory study was performed at the
index drug-eluting stent (DES) implantation and at the outpatient visit between 3moths
and 12months later. We categorized patients into four groups based on initial and
follow-up hemoglobin levels (normal, anemia-corrected, newly developed anemia,
sustained anemia groups).
Results: We analyzed consecutive 9292 patients performed PCI with DESs from
January, 2004 to December, 2009. Of these, 4300 subjects with initial and follow-up
hemoglobin were enrolled and median follow up period was 25.6 months. After
adjusting multiple covariates, sustained anemia group demonstrated a significant
increase in a hazard ratio (HR) of a composite of death, myocardial infarction, and
stroke (HR=2.745, p<0.001, 95% confidence interval (CI) 2.030 to 3.712) comparing
with normal group. There was also significant increase of HR in the corrected anemia
group (p<0.001, 95% CI 1.359 to 2.539) but this group shows better clinical outcome
than sustained anemia group.
Kaplan-Meier curve of cumulative free from MACCE rate for patients who
underwent DES, according to anemia group.
Conclusion: Follow up of hemoglobin is important and the correction of anemia during
follow up periods can improve patients’ clinical outcomes. The effort to establish
treatment options for anemia and to detect and treat underlying medical problems
should be asserted.
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Background: The optimal threshold for predicting mortality with troponin I, in
particular in patients with renal dysfunction, remains poorly defined.
Methods: Consecutive patients were included if they were evaluated and discharged
from the emergency department (ED) at any of the 11 participating centers between
January 2006 and December 2009. Participants were required to have at least 2 serial
troponin I values in the ED. All troponin I values were obtained using the same assay.
The study sample was randomly divided into a derivation and validation cohort. The
derivation data set was used to calculate a troponin I threshold for a 30 day all-cause
mortality. Bootstrap estimates, sampling with replacement, yielded the average best
cut off and 95% CI. Performance of the threshold was then evaluated in a validation
cohort.
Results: There were 71,666 patients in the study cohort. The bootstrap estimate of the
cut off value of troponin I in the derivation cohort was 0.06 (95% CI: 0.05 – 0.07).
Predicted mortality by estimated GFR and troponin I values in the derivation and
validation cohorts are shown in the figures.
Conclusion: In this cohort, very minor troponin I elevations were predictive of 30-
day mortality after presentation to the ED for all levels of renal function.
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Regular exercise improve FMD, carotid IMT, and EPC in PCI patients
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Background: As exercise improves endothelial dysfunction, we investigated the effect
of training on angiogenesis by measuring the number of circulating endothelial
progenitor cells (EPCs), and tested vascular function by flow-mediated dilation (FMD)
and carotid intima-media thickness (IMT) in patients with percutaneous coronary
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